This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Beta

We welcome your feedback, which will help improve this site.

Feedback form

Research and Innovation for Global Health Transformation - Call 1 Stage 1 Minutes

 

Contents

Research and Innovation for Global Health Transformation (RIGHT) Programme 

Minutes of the RIGHT Call 1 Stage 1 Funding Committee Meeting

Meeting held on 19 October 2018 by Webinar

In attendance:

Funding Committee Members 

Professor Tom Solomon (Chair)

Dr Marie-Paule Kieny (Deputy Chair)

Professor Pamela Abbott

Dr Mary AmauyunzuNyamongo

Professor Ben Anderson 

Professor Marcello Barcinski

Professor Kalipso Chalkidou

Professor Lara Fairall

Professor Elizabeth Grant

Professor Li Yang Hsu 

Professor Moffat Nyirenda 

Dr David Phipps 

Dr Paul Saunderson

Apologies

Professor Hermann Feldmeier (provided written comments)

Professor Pierre-Marie Preux (provided written comments) 

Professor Janaka da Silva (provided written comments)

Secretariat

Dr Mike Rogers (NIHR CCF)

Dr Debbie Willis (NIHR CCF)

Dr Nicola Commander (NIHR CCF)

Ms Daniela Toale (NIHR CCF)

Mr Bryan Dar (NIHR CCF)

Ms KatalinTorok (NIHR CCF)

Observing

Mr David Chandler (Public Member)

Ms Una Rennard (Public Member)

Ms Laurence Poos (DHSC)

Ms Alison MacEwen (DHSC)

Dr Alex Ademokun (DHSC)

RIGHT Call 1 Stage 1 applications considered

NIHR200097: Improving the access to and delivery of epilepsy care in India and Uganda as exemplars of low and middle income countries (IDEAL)

Conflicts: Professor Tom Solomon

Outcome: Reject

NIHR200124: Sustainable Treatment, Reducing Access Barriers and Promoting Participation in Epilepsy (STRAPP) 

 

Conflicts: None
Outcome: Reject

NIHR200125: Improving experiences of severe stigmatising skin diseases in Ghana and Ethiopia

Conflicts: Dr Paul Saunderson, Professor Moffat Nyirenda

Outcome: Invite to Stage 2

NIHR200126: Reducing the prevalence of hepatocellular carcinoma by preventing mother to child transmission of hepatitis B: A double-blind, randomised, placebocontrolled trial of tenofovir disoproxil fumarate

Conflicts: Professor Marcello Barcinski

Outcome: Reject

NIHR200127: REducing Stigmatising skin cOnditions prevaLent in Vietnamese amputEes; RESOLVE

Conflicts: Professor Kalipso Chalkidou

Outcome: Reject

NIHR200128: Towards elimination of hepatitis B elimination in Africa: the Intervention for Avoidance of Neonatal Transmission of hepatitis B in Africa (INFANT-B) study.

Conflicts: Professor Kalipso Chalkidou

Outcome: Reject

NIHR200129: REDRESS: Reducing the Burden of Severe Stigmatising Skin Diseases through equitable person-centred approaches to health systems strengthening

Conflicts: Dr Paul Saunderson

Outcome: Invite to Stage 2

NIHR200130: Improving diagnostic and treatment regimes for HIV-associated Kaposi’s sarcoma patient outcome

Conflicts: None

Outcome: Reject

NIHR200131: Using lab-on-a-chip solutions to reduce deaths caused by EBVpositive nasopharyngeal cancer - a proof of principle approach for improving cancer outcomes in the Global South

Conflicts: Professor Kalipso Chalkidou

Outcome: Reject

NIHR200132: Transforming the Treatment and Prevention of Leprosy and Buruli ulcers in Low and Middle-Income Countries (LMICs)

Conflicts: Dr Paul Saunderson, Professor Kalipso Chalkidou, Professor Tom Solomon

Outcome: Invite to Stage 2

NIHR200133: Evaluation and Transfer of mobile whole slide tissue scanners and liquid biopsies to deliver fast and precise diagnosis for improved outcomes of children and young adults with EBV-driven lymphoma: a joint Tanzanian and Ugandan Paediatric Oncology Network Initiative

Conflicts: None

Outcome: Invite to Stage 2

NIHR200134: Epilepsy in vulnerable populations of sub-Saharan Africa

Conflicts: Professor Pierre-Marie Preux

Outcome: Shortlisted to Stage 2

NIHR200135: ECLIPSE (Empowering Cutaneous Leishmaniasis patients: an Intervention Programme to reduce time to treatment and Stigma via community Education).

Conflicts: None

Outcome: Invite to Stage 2

NIHR200136: Reducing cutaneous Leishmaniasis in Ethiopia

Conflicts: Professor Liz Grant

Outcome: Reject

NIHR200137: EN-EPILEPSIES Every Newborn - Epilepsy Prevention In LMIC, Enhancing care, Parent Support & Impairment Evaluation Study 

Conflicts: Professor Moffat Nyirenda, Professor Pierre-Marie Preux

Outcome: Invite to Stage 2

NIHR200138: Improving the detection and management of Burkitt lymphoma in subSaharan Africa and beyond

Conflicts: Professor Tom Solomon

Outcome: Invite to Stage 2

NIHR200139: Innovative approaches to informing policy and guidance– multidimensional strategies that develop an evidence base around scabies in Brazil, Ghana and Papua New Guinea

Conflicts: None

Outcome: Reject

NIHR200140: Social Sciences for Severe Stigmatising Skin Diseases (the 5-S Foundation)

Conflicts: None

Outcome: Invite to Stage 2

NIHR200141: STARS - Strengthening Treatment, Access and Response to epilepsy in South America

Conflicts: Professor Pierre-Marie Preux

Outcome: Reject

NIHR200142: Comprehensive assessment of host and pathogen determinants of infection-related cancers in a large prospective study in China

Conflicts: None

Outcome: Reject

NIHR200143: Reducing the burden of Kaposi’s sarcoma and Burkitt lymphoma in sub-Saharan Africa.

Conflicts: Professor Moffat Nyirenda

Outcome: Invite to Stage 2

NIHR200144: Prevention of epilepsy from birth-related brain injury

Conflicts: Professor Kalipso Chalkidou

Outcome: Invite to Stage 2

NIHR200145: Biomarkers for Sensing Human Skin Cell Reprogramming in Response to Mycobacterium leprae As Early Diagnosis for Leprosy: Direct Implementation in LMICs 

Conflicts: Professor Liz Grant

Outcome: Reject

NIHR200146: Epilepsy in Children in East Africa; Aetiology, Co-morbidities and Seizure Outcomes

Conflicts: Professor Pierre-Marie Preux

Outcome: Invite to Stage 2

NIHR200147: Epstein Barr virus and human Herpesvirus 8 associated lymphomas and lymphoproliferative disorders in Africa – to achieve improved diagnosis and management, and better understanding of aetiopathogenesis.

Conflicts: Professor Kalipso Chalkidou

Outcome: Invite to Stage 2